As biotechnology continues to revolutionise global healthcare, drug development, and life sciences innovation, the BIO International Convention 2025 served as a premier platform for exploring the latest scientific breakthroughs, regulatory trends, and emerging technologies shaping the future of the biotech ecosystem. Held in Boston from June 16–19, the convention spotlighted the transformative potential of biotech.
The convention featured impactful sessions on the future of AI in drug discovery, IP for AI-generated inventions, oncolytic investment trends, rare disease therapeutics, regulatory frameworks, and commercialisation strategies. Key discussions also covered the Inflation Reduction Act, AI’s role in improving healthcare access, and the evolving US and EU biotech policy landscapes, highlighting the convergence of science, regulation, and AI-driven transformation in biopharma.
LexOrbis Partners Manisha Singh and Abhai Pandey attended the convention, engaging in strategic conversations on IP protection for AI-assisted innovations, global patent strategies, and legal frameworks supporting R&D in life sciences.